Navigation Links
Rare genetic mutations protect against hypertension
Date:4/6/2008

mutations in single genes. Such patients are often identified through family histories of extreme blood pressure. To date, his group has found a score of gene mutations that lower or raise blood pressure, including those that cause the extreme low blood pressure found in patients with Gitelman and Bartter syndromes.

We used knowledge of the spectrum of mutations that cause Gitelman and Bartter syndromes to sort among the hundreds of sequence changes we observed to identify those that are either known or highly likely to alter the function of the (gene) encoded proteins, Lifton explained.

By sequencing each of the three genes obtained from DNA samples from 3,125 participants in the Framingham Heart Study, and doing additional biochemical, genetic and genomic analysis, the HHMI team found functional mutations in one of the genes in at least 1 of every 64 of the study's participants sampled.

The results show that nearly 2 percent of the FHS cohort has a defective copy of one of these three genes, Lifton said. Unlike patients with Gitelman and Bartter syndromes, these subjects have only one defective copy, not two.

Lifton's group then tracked the influence of the mutation on blood pressure in FHS subjects aged 40-60, a time of life when hypertension manifests itself and can pose serious health risks.

We found that these mutation carriers have a 60 percent reduction in their risk of developing hypertension and have significantly lower blood pressure than those who do not have mutations, Lifton said. The influence of the mutation, he added, approximates effects achieved with drugs used to lower blood pressure.

The practical upshot of the new work, according to Lifton, could be potential new drugs to mimic the effects of the mutation by selectively inhibiting a single gene or several genes.

In addition, the study more broadly underscores the value of genetic analysis -- resequencing of genes and genomes to ferret
'/>"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Answer to troublesome question of why some genetic assoc. studies have failed replication attempts
2. Peter J. McGuire, MB BCh, is awarded the 2008-2009 Genzyme/ACMGF Clinical Genetics Fellowship
3. Genetic Engineering & Biotechnology News reports on cancer biomarkers
4. Michigan Tech researchers link 11 genetic variations to type 2 diabetes
5. Major collaboration uncovers surprising new genetic clues to diabetes
6. Major international collaboration offers new clues to genetics of type 2 diabetes
7. Need for federal protection against genetic discrimination
8. Deadly genetic disease prevented before birth in zebrafish
9. Plant Physiology and TAIR partnership will provide genetic information to public database
10. Epigenetic changes discovered in major psychosis
11. A common genetic mechanism discovered in nitrogen-fixing plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... July 30, 2015 after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
(Date:7/7/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a biometric ... revised version of one of its first 30 second commercials will ... New York , Chicago , ... metro areas.    , , , , ... the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... While scientists are using the human genome to associate ... ensure they are accounting for natural variations in those ... analyzing data," says Dr. Xu, biostatistician in the Medical ... always some difference in ethnic backgrounds across a study ...
... bacteria on ocean-bottom rocks are more abundant and diverse ... oceanic crust, according to results of a study reported ... The findings pose intriguing questions about ocean chemistry ... considered a barren plain dotted with hydrothermal vents, the ...
... life is feeding on fresh volcanic rock and flourishing ... thought possible. According to a study published May 28 ... on oceanic crust in concentrations that are thousands- to ... than what is found in the overlying waters. ...
Cached Biology News:Statistical tool could explain gene study variations 2Bacteria 'feed' on earth's ocean-bottom crust 2Scientists find bacteria thriving on a feast of seafloor rock 2
(Date:7/29/2015)... Inc. (NYSE: BIOA ) today announced that ... resigned.  The Company has hired Andrew Ashworth , ... 2014, as full time interim CFO and has launched ... Andy Ashworth began his employment today, to overlap ... was the Company,s CFO from September 2011 to December ...
(Date:7/29/2015)... July 29, 2015 ... the addition of the "Global Biosimilars Market, ... The Global Biosimilars Market, 2015 - ... rapidly growing biosimilars market. With the blockbuster biologics ... minimize costs, biosimilars are being viewed as viable ...
(Date:7/29/2015)... 2015  Pfenex Inc. (NYSE MKT: PFNX) announced today ... released on Thursday, August 13, 2015, before the open ... will host a conference call to discuss the financial ... outlining the financial results and business update will be ... call 1-866-376-8058 (US) or 1-412-542-4131 (international) and reference Pfenex ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... D.C. - Despite recent legislative setbacks, proponents of ... and they urged members of the United States Senate ... strong net neutrality provisions are included. , ,The pro-neutrality ... businesses, urged the Senate to reject the telecommunications bill ...
... at the midpoint of 2006 already. The first half stock market ... months ago, the Dow was up twice that level but took ... bounce back in July. The NASDAQ has really taken a hit ... know about continued oil price increases, once again surpassing the $3/gallon ...
... Madison, Wis. - The relocation of one area biotech ... to innovation could take it even higher. , ,And while ... analysis of molecular interactions on bioarrays, is not yet in ... friction-free environment" for high-tech product development, according to president and ...
Cached Biology Technology:Net neutrality will be back, supporters vow 2Net neutrality will be back, supporters vow 3Net neutrality will be back, supporters vow 4First half of 2006 roundup: Big Pharma trumps biotech 2First half of 2006 roundup: Big Pharma trumps biotech 3First half of 2006 roundup: Big Pharma trumps biotech 4First half of 2006 roundup: Big Pharma trumps biotech 5First half of 2006 roundup: Big Pharma trumps biotech 6Madison biotech continues its climb 2Madison biotech continues its climb 3Madison biotech continues its climb 4
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
Rat polyclonal to acetyl Salicylic Acid ( Abpromise for all tested applications)....
Request Info...
... Quality 96 Well BAC Prep; ... preparation from 1.5ml 2xYT cultures; ... automated fluorescent sequencing for small ... ProPrep strategy which minimizes shearing ...
Biology Products: